Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity (Q43963325)

28 November 2017

Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity (English)

1 reference

28 November 2017

0 references

1 reference

4

D Allan Butterfield

1 reference

28 November 2017

Jaroslaw Kanski

1

1 reference

PubMed ID

11959460

28 November 2017

Sridhar Varadarajan

series ordinal

2

1 reference

PubMed ID

11959460

28 November 2017

Marina Aksenova

series ordinal

3

1 reference

28 November 2017

1 March 2002

1 reference

Biochimica et Biophysica Acta

28 November 2017

1 reference

28 November 2017

1586

1 reference

28 November 2017

190-198

1 reference

28 November 2017

2

1 reference

Amyloid beta-protein and the genetics of Alzheimer's disease

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Increased nuclear DNA oxidation in the brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Copper, iron and zinc in Alzheimer's disease senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35).

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Is Oxidative Damage by β-Amyloid and Prion Peptides Mediated by Hydrogen Atom Transfer from Glycine α-Carbon to Methionine Sulfur within β-Sheets?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Evidence for synaptic apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Thirty years of synaptosome research

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

[18] Quantification of β-sheet amyloid fibril structures with thioflavin T

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Redox-active iron mediates amyloid-beta toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2801%2900097-7

7 January 2021

10.1016/S0925-4439(01)00097-7

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

11959460